156679-34-4

Wuhan Chemstan Biotechnology Co., Ltd.

Telephone027-65317797 15926423062

Websitehttp://www.chemstan.com/

Biolab Reagents

Telephone18108604356

Websitehttps://www.biolabreagent.com/

Atagenix Laboratories

Telephone027-87008169 17762441161

Websitehttps://www.abinscience.com/

AntibodySystem Laboratories SAS

Telephone 33175446423

Websitehttp://www.antibodysystem.com

Animal Model:	Male Sprague-Dawley rats^[1]
Dosage:	1 and 3 mg/kg
Administration:	Intraperitoneal injection, 1 h before administration of Sephadex for the 24 h study or 1 h before and at 24 and 48 h after Sephadex for the 72 h study
Result:	Inhibited the neutrophilia at 24 h after Sephadex. At 72 h after Sephadex, significantly reduced the neutrophil influx into bronchoalveolar lavage fluid (BALF) but had no inhibitory effect on eosinophil number.

Animal Model:	6- to 8-week-old female BALB/c mice, septic shock model^[2]
Dosage:	0.8, 4 or 20 μg/mouse
Administration:	IV, single dose
Result:	Injection 0.5 h prior to Salmonella abortus-derived endotoxin (LD₁₀₀ dose) administration prevented lethality at a dose of 20 μg per mouse and provided partial protection at lower doses. Injection of 10 μg per mouse provided significant protection 0.5 h before, 0.5 h after, or 1 h after endotoxin injection but little protection 2 h after endotoxin injection.

Hazard Information

Name	Lenercept
CAS	156679-34-4